Zepp Health Corp.
Zepp Health Corp. Q3 FY2024 earnings call
November 19, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-11-19
Management highlights
• Self-branded sales grew 10% QoQ and contributed over 95% of total revenue, with Q3 marking the highest sequential growth in Amazfit product sales for the year. • Hit the highest gross margin in history due to a better product mix with higher gross margins. • T-Rex 3 smartwatch launched in September at IFA Berlin was well-received but faced supply constraints. • New products like Amazfit UP Open Wearable Stereo earbuds and Helio Ring expanded the product ecosystem. • Zepp OS 4.0 and redesigned Zepp App enhanced user experience with health-focused features. • Partnered with Wild.AI for female health insights and expanded the Amazfit athlete team. • Partnered with HYROX for fitness racing events, integrating dedicated app for health metrics. • Focus on cost management, reducing operating expenses from ~RMB 180M in 2022 to ~RMB 100M by end of 2024.
Segment performance
Self-branded sales increased by 10% quarter-over-quarter and contributed more than 95% of the company's total revenue. Q3 gross margin reached 41%, the highest in the company's history. The Amazfit product sales saw the highest sequential growth for the year, with self-branded sales driving the expansion.
Guidance
• Q4 revenue guidance is in the range of USD 55 million to USD 70 million, with self-branded products expected to contribute over 90% of revenue, representing a 29% to 65% growth compared to Q3 2024. • Continue share buyback program throughout 2026. • Confident in maintaining momentum from Q3 and capitalizing on emerging opportunities.
Risks
• Supply constraints on T-Rex 3 due to strong-than-expected demand, impacting Q3 top line. • Global macroeconomic headwinds affecting discretionary consumer spending. • Competition offering larger discounts to acquire users. • Foreign exchange rate fluctuations impacting financial results.
Q&A highlights
Q: You're expecting a major spike in revenue in Q4. Could you provide more details on other avenues or products where you expect real growth?
A: T-Rex 3 will be a major contributor, plus newly launched OWS earbuds and Helio Ring provide a comprehensive health solution. Q4 is traditionally a strong selling season with events like Double 11, Prime Day, Black Friday, and Christmas.
Q: Where exactly is the bottleneck in terms of the supply constraints for T-Rex 3?
A: Demand for T-Rex 3 spiked sharply, outpacing initial production, but factories are running 24/7 to resolve supply constraints in Q4.
Q: What really happened with the ForEx loss in Q3 and how does it affect Q4?
A: RMB to dollar appreciated significantly in the last 15 days of Q3, causing a ForEx loss, but Q4 is expected to have a tailwind from FX, and stripping out FX impact, profitability improved in Q3.
Q: How sustainable is the expected growth in sales looking further ahead?
A: T-Rex 3 is a successful product, and 2025 will have a more balanced new product launch window with renewals of Bip, Active, and Balance series, leading to sustainable growth in subsequent quarters.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 19, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.